Hormone Replacement Therapy Market Segmented On The Basis Of Product, Route Of Administration, Type Of Disease, Region And Forecast To 2027

17/set/2020 13:30:28 Grand View Research Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Hormone Replacement Therapy Market1

San Francisco, 17 Sep 2020: The Report Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill, gel, skin patch, cream or spray form. It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market. Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world. For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Access Research Report of Hormone Replacement Therapy Market https://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market

Further key findings from the report suggest:

  • The estrogen replacement therapy segment dominated the overall market in terms of revenue share in the year 2019. On the other hand, the parenteral segment is likely to showcase the fastest growth rate over the forecast period from 2020 to 2027, owing to the rising number of hormonal disorders
  • Menopause is likely to showcase the fastest growth rate over the forecast period. Women are vulnerable to certain diseases and conditions such as osteoporosis and hot flashes during and after menopause. About 73% of postmenopausal women suffer from hot flashes
  • North America dominated the overall hormone replacement therapy market in terms of revenue share in the year 2019. The increase in the incidence rate of hypogonadism due to a rise in obesity and poor health in the geriatric population drive the market. According to the American Academy of Family Physicians, more than 2.5 million Americans received testosterone treatment in U.S alone in 2014
  • Some of the key players in this market are Abbott Laboratories; Novartis; Pfizer, Inc.; Mylan Laboratories; Merck and Co.; Novo Nordisk; Bayer Healthcare; Eli Lilly; and Genentech. 

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global hormone replacement therapy market based on product, route of administration, type of disease, and region:

Hormone Replacement Therapy Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Estrogen Hormone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy

Hormone Replacement Therapy Route of Administration Outlook (Revenue, USD Million, 2016 - 2027)

  • Oral
  • Parenteral
  • Transdermal
  • Others

Hormone Replacement Therapy Type of Disease Outlook (Revenue, USD Million, 2016 - 2027)

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

Hormone Replacement Therapy Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 Access Press Release of Hormone Replacement Therapy Market @ https://www.grandviewresearch.com/press-release/global-hormone-replacement-therapy-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl